注射用盐酸万古霉素制剂的质量评价研究

于童;赵荣生 ;周勇 ;翟所迪

中国药学杂志 ›› 2009, Vol. 44 ›› Issue (21) : 1662-1665.

PDF(2506 KB)
PDF(2506 KB)
中国药学杂志 ›› 2009, Vol. 44 ›› Issue (21) : 1662-1665.
论文

注射用盐酸万古霉素制剂的质量评价研究

  • 于童 1,2 ,赵荣生 1* ,周勇 1 ,翟所迪 1
作者信息 +

Quality Evaluation of Vancomycin Hydrochloride for Injection

  • YU Tong 1,2 , ZHAO Rong-sheng 1* , ZHOU Yong 1 , ZHAI Suo-di 1
Author information +
文章历史 +

摘要

目的 对目前国内市场 注射用盐酸万古霉素制剂 进行质量评价,为临床选择品种提供科学的 依据 。 方法 建立注射用盐酸万古霉素中万古霉素 B 及有关物质测定的高效液相色谱定量分析方法,同时考察性状、 pH 值、不溶性微粒和万古霉素效价,按国家药品标准方法对 4 个厂家共 10 个批次注射用盐酸万古霉素进行质量评价。 结果 在本实验条件下,按照国家药品标准评价, 4 个厂家注射用盐酸万古霉素性状、 pH 值、不溶性微粒和万古霉素效价均合格;万古霉素 B 及有关物质, A 厂、 C 厂 3 个批次 的产品均合格, B 厂的产品有 2 批次不合格, D 厂的产品有 1 批次不合格。 4 个厂家 10 批次产品按日本药局方、英国药典和美国药典标准评价均合格。 结论 本实验采集的样品按中国国家药品标准评价, A 厂和 C 厂的产品均合格, B 厂和 D 厂部分批次的产品质量不符合要求。

Abstract

OBJECTIVE To evaluate the product quality of vancomycin hydrochloride for injection. METHODS The HPLC-UV method was established to determine the content of vancomycin B and related substances. The characteristics , pH, insoluble particulate matter and potency were evaluated at the same time. All the samples were evaluated based on National Drug Standards. RESULTS According to National Drug Standards, the results of the characteristics, pH, insoluble particulate matter and potency of all samples meet the standards, while the vancomycin B and related substances of 3 batches preparations of 2 manufactories were unqualified. All the samples meet the standard of JP15, USP30 and BP2007. CONCLUSION According to National Drug Standards, the products of manufactory A and C were all qualified, and the products of manufactory B and D were partially qualified.

关键词

注射用盐酸万古霉素 / 万古霉素 B / 高效液相色谱

Key words

vancomycin hydrochloride for injection / vancomycin B / HPLC / quality evaluation

引用本文

导出引用
于童;赵荣生 ;周勇 ;翟所迪 . 注射用盐酸万古霉素制剂的质量评价研究[J]. 中国药学杂志, 2009, 44(21): 1662-1665
YU Tong;ZHO Rong-sheng;ZHOU Yong;ZHI Suo-di . Quality Evaluation of Vancomycin Hydrochloride for Injection[J]. Chinese Pharmaceutical Journal, 2009, 44(21): 1662-1665

参考文献


[1] USP(30th) [S].2007:3449-3451.
[2] JP(15th)[S].2006:1221-1223.
[3] BP(2007) Vol = 3 \* ROMAN III [S].2006:2980-2981.
[4] Drug Standard of China by SFDA [S].WS1-(X-115)-2006Z:1-2.
[5] <>Ch.P ( 2005 ) Vol Ⅱ[ S ] .2005:Appendices 79-84.
[6] <>Ch.P ( 2005 ) Vol Ⅱ [S].Supplement,2009:187-188.
( 收稿日期 : 2009-03-10 )


PDF(2506 KB)

59

Accesses

0

Citation

Detail

段落导航
相关文章

/